Two Sigma Advisers
PDLI

Two Sigma Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-89,269
Closed -$290K 2665
2019
Q4
$290K Sell
89,269
-379,221
-81% -$1.23M ﹤0.01% 2078
2019
Q3
$1.01M Sell
468,490
-140,400
-23% -$303K ﹤0.01% 1428
2019
Q2
$1.91M Sell
608,890
-11,400
-2% -$35.8K ﹤0.01% 1228
2019
Q1
$2.31M Sell
620,290
-21,100
-3% -$78.5K 0.01% 1160
2018
Q4
$1.86M Sell
641,390
-43,303
-6% -$126K 0.01% 1198
2018
Q3
$1.8M Buy
684,693
+9,600
+1% +$25.3K ﹤0.01% 1278
2018
Q2
$1.58M Sell
675,093
-70,500
-9% -$165K ﹤0.01% 1407
2018
Q1
$2.19M Sell
745,593
-143,100
-16% -$421K 0.01% 1208
2017
Q4
$2.44M Sell
888,693
-51,900
-6% -$142K 0.01% 1154
2017
Q3
$3.19M Buy
940,593
+88,538
+10% +$300K 0.01% 994
2017
Q2
$2.11M Sell
852,055
-106,238
-11% -$262K 0.01% 1181
2017
Q1
$2.18M Sell
958,293
-63,381
-6% -$144K 0.01% 1212
2016
Q4
$2.17M Buy
1,021,674
+58,362
+6% +$124K 0.01% 1133
2016
Q3
$3.23M Sell
963,312
-91,800
-9% -$308K 0.01% 824
2016
Q2
$3.31M Sell
1,055,112
-372,700
-26% -$1.17M 0.02% 687
2016
Q1
$4.76M Sell
1,427,812
-58,420
-4% -$195K 0.03% 517
2015
Q4
$5.26M Buy
1,486,232
+104,942
+8% +$371K 0.03% 431
2015
Q3
$6.99M Sell
1,381,290
-88,207
-6% -$447K 0.04% 392
2015
Q2
$9.45M Sell
1,469,497
-31,012
-2% -$199K 0.07% 313
2015
Q1
$10.6M Buy
1,500,509
+983,000
+190% +$6.92M 0.08% 300
2014
Q4
$3.99M Sell
517,509
-333,900
-39% -$2.57M 0.03% 528
2014
Q3
$6.36M Sell
851,409
-68,100
-7% -$509K 0.05% 394
2014
Q2
$8.9M Sell
919,509
-464,100
-34% -$4.49M 0.07% 298
2014
Q1
$11.5M Buy
1,383,609
+249,500
+22% +$2.07M 0.1% 193
2013
Q4
$9.57M Sell
1,134,109
-640,800
-36% -$5.41M 0.09% 222
2013
Q3
$14.1M Buy
1,774,909
+371,854
+27% +$2.96M 0.17% 125
2013
Q2
$10.8M Buy
+1,403,055
New +$10.8M 0.15% 121